methylprednisolone acetate has been researched along with Forestier-Certonciny Syndrome in 1 studies
Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salvarani, C | 1 |
| Cantini, F | 1 |
| Olivieri, I | 1 |
| Barozzi, L | 1 |
| Macchioni, L | 1 |
| Boiardi, L | 1 |
| Niccoli, L | 1 |
| Padula, A | 1 |
| Pulsatelli, L | 1 |
| Meliconi, R | 1 |
1 trial available for methylprednisolone acetate and Forestier-Certonciny Syndrome
| Article | Year |
|---|---|
Corticosteroid injections in polymyalgia rheumatica: a double-blind, prospective, randomized, placebo controlled study.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Bursitis; Double-Blind Method; Female; Humans; Ma | 2000 |